Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
US: ABBV

AbbVie Inc.

Healthcare
$265.79 +0.00 (+0.00%) as of 2026-08-26 08:02 UTC
Market Cap$471.2B
Volume3.67M

AbbVie Inc. (ABBV) is a $471.2B healthcare company trading at $265.79 (+0.0% today). Figures from SEC EDGAR and market feeds; updated 2026-08-26 08:02 UTC.

52-Week Range
Low $196.23High $267.47

What AbbVie Inc. does

AbbVie is a global biopharmaceutical company that researches, develops, manufactures, and sells medicines and therapies focused on immunology, neuroscience, oncology, and aesthetics. The company was spun off from Abbott Laboratories and became independent on January 1, 2013. AbbVie operates as a single global business segment with research and development plus supply chain functions handled globally, while commercial activities are organized by geographic region or therapeutic area.

Summarized from AbbVie Inc.’s SEC filings · Read the filing ↗

Key facts

Quote
Price$265.79
Change (1D)+0.00 (+0.00%)
Market cap$471.2B
Volume3.67M shares
52-week range$196.23 – $267.47
Returns
52-week return+35.4%

Revenue, margins & earnings

FY2021 Net income: $11.5BFY2021 Taxes & interest: $6.38BFY2021 Operating costs: $38.3B$56.2BFY2021FY2022 Net income: $11.8BFY2022 Taxes & interest: $6.28BFY2022 Operating costs: $39.9B$58.1BFY2022FY2023 Net income: $4.86BFY2023 Taxes & interest: $7.89BFY2023 Operating costs: $41.6B$54.3BFY2023FY2024 Net income: $4.28BFY2024 Taxes & interest: $4.86BFY2024 Operating costs: $47.2B$56.3BFY2024FY2025 Net income: $4.23BFY2025 Taxes & interest: $10.8BFY2025 Operating costs: $46.1B$61.2BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-18
  • 2026-08-18Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERM32,710$2.58M
  • 2026-08-18Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERSELL-32,710$8.18M
  • 2026-08-18Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERM-32,710—
Sign in to see all transactions →

Company news

View all →

Questions this page answers

What does AbbVie Inc. do?

AbbVie is a global biopharmaceutical company that researches, develops, manufactures, and sells medicines and therapies focused on immunology, neuroscience, oncology, and aesthetics.

What is ABBV's valuation?

ABBV trades at $265.79, as of 2026-08-26.

When did ABBV last file with the SEC?

AbbVie Inc.'s most recent SEC filing on record is a 8-K filed 2026-08-18. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-08-26 08:02 UTC. This page is also available as JSON at /api/data?ticker=ABBV and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ABBV and 5,000+ tickers.

Create a free account — keep ABBV
For your agent
GET /api/data?ticker=ABBV

This page as JSON via rel="alternate" · REST API docs · MCP server (53 tools) · llms.txt